Home
>
National Drug Code (NDC)
>
NAGLAZYME
NAGLAZYME - 68135-020-01 - (galsulfase)
Drug Information of NAGLAZYME
| Product NDC: | 68135-020 |
| Proprietary Name: | NAGLAZYME |
| Non Proprietary Name: | galsulfase |
| Active Ingredient(s): | 5 mg/5mL & nbsp; galsulfase |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NAGLAZYME
| Product NDC: | 68135-020 |
| Labeler Name: | BioMarin Pharmaceutical Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125117 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20050609 |
Package Information of NAGLAZYME
| Package NDC: | 68135-020-01 |
| Package Description: | 1 VIAL in 1 CARTON (68135-020-01) > 5 mL in 1 VIAL |
NDC Information of NAGLAZYME
| NDC Code | 68135-020-01 |
| Proprietary Name | NAGLAZYME |
| Package Description | 1 VIAL in 1 CARTON (68135-020-01) > 5 mL in 1 VIAL |
| Product NDC | 68135-020 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | galsulfase |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20050609 |
| Marketing Category Name | BLA |
| Labeler Name | BioMarin Pharmaceutical Inc. |
| Substance Name | GALSULFASE |
| Strength Number | 5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
